<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00521391</url>
  </required_header>
  <id_info>
    <org_study_id>3200-0637200</org_study_id>
    <secondary_id>3200-0637200</secondary_id>
    <nct_id>NCT00521391</nct_id>
  </id_info>
  <brief_title>Physical Activity as an Aid for Smoking Cessation</brief_title>
  <acronym>PHASMO</acronym>
  <official_title>Physical Activity as an Aid for Smoking Cessation: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Lausanne Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Including a tailored moderate-intensity physical activity intervention in a standard smoking&#xD;
      cessation treatment program (pharmaceutical treatment and counseling) increases the chances&#xD;
      of quitting and reduces nicotine withdrawal symptoms, negative moods, stress, and weight&#xD;
      gain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective is to determine whether a tailored physical activity intervention&#xD;
      involving moderate-intensity exercise is an added value to a standard smoking cessation&#xD;
      intervention in term of likelihood of smoking abstinence.&#xD;
&#xD;
      The secondary objectives are 1) to determine whether this tailored physical activity&#xD;
      intervention prevents weight gain, reduces withdrawal symptoms, stress and improve mood and&#xD;
      self-confidence in quitting; 2) to assess the effect of this tailored physical activity&#xD;
      intervention on body composition and leptin concentration.&#xD;
&#xD;
      We assess this intervention in a randomized controlled trial of 600 sedentary adults regular&#xD;
      smokers recruited from the community allocated into one of the two groups (intervention group&#xD;
      vs. control group) during a 10-week period and 3 follow-up visits (6 and 12 months&#xD;
      follow-up). All subjects (intervention and control groups) participate in a smoking cessation&#xD;
      program composed of a pharmacological treatment (including nicotine replacement therapy) and&#xD;
      counseling. The intervention group attend the 10-week physical activity program blending&#xD;
      moderate-intensity exercise (Swiss nationwide implemented program entitled &quot;Allez Hop!&quot;) and&#xD;
      lifestyle physical activity and the control group a 10-week health education program to&#xD;
      ensure equal contact condition.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    End of the recruitment&#xD;
  </why_stopped>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">December 2005</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>smoking cessation</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>weight change</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">600</enrollment>
  <condition>Tobacco Dependence</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Physical Activity</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a tailored physical activity intervention involving moderate-intensity exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Allez Hop</intervention_name>
    <description>a tailored physical activity intervention involving moderate-intensity exercise</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Current daily smoker &gt;10 or more cigarettes per day&#xD;
&#xD;
          2. Having smoked (on average &gt; 10 cigarettes/day) regularly for at least 3 years&#xD;
&#xD;
          3. Age between 18 and 65 years&#xD;
&#xD;
          4. Sedentary lifestyle defined as less than 20 minutes a day of moderate-intensity&#xD;
             physical assessed by the Swiss Baseline Questionnaire.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Current pharmacological agent use to quit smoking&#xD;
&#xD;
          2. Medical problems that would alter training responses: arthritis, heart disease, and&#xD;
             orthopedic problems&#xD;
&#xD;
          3. Presence of an unstable medical condition&#xD;
&#xD;
          4. Current or recent major cardiovascular event, such as recent myocardial infarction&#xD;
             (&gt;12 months) or stroke, angina pectoris, major arrhythmia&#xD;
&#xD;
          5. Current psychiatric illness&#xD;
&#xD;
          6. Alcohol (&gt; 4 drinks/day for men and &gt; 3 drink/d. for women), or/and other substance&#xD;
             abuse&#xD;
&#xD;
          7. Current or planned pregnancy&#xD;
&#xD;
          8. Systematic skin disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacques Cornuz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Lausanne</affiliation>
  </overall_official>
  <verification_date>August 2007</verification_date>
  <study_first_submitted>August 24, 2007</study_first_submitted>
  <study_first_submitted_qc>August 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2007</study_first_posted>
  <last_update_submitted>August 24, 2007</last_update_submitted>
  <last_update_submitted_qc>August 24, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2007</last_update_posted>
  <keyword>smoking cessation</keyword>
  <keyword>nicotine</keyword>
  <keyword>physical activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

